The University of Michigan has launched a new transdisciplinary institute that will bolster research collaborations and strengthen community engagement to address the national opioid overdose crisis, which leads to nearly 200 deaths per day across the United States.

In this long-form article profiling people living with chronic pain, Daniel Clauw, M.D., provides insights into the science of treating pain and matching patients with the right treatments. Clauw is a professor of anesthesiology and executive director of pain & opioid research.

Medication guidelines for post-surgical opioid prescribing were associated with a lower rate of long-term opioid use and much lower amounts of opioid prescription fills in Michigan compared with the rest of the U.S.

Her research aims to provide foundational data to establish a future clinical trial assessing postoperative outcomes in patients who receive phenylephrine or norepinephrine.

The idea of performing awake spinal anesthesia on a baby sounded a little intimidating to Ashlee Holman, M.D., when first approached by urologist John Park, M.D.

Michigan Anesthesiology welcomes 27 newly matched residents to our residency program.

The program, funded through the U-M Medical School Office of Research, provides funding for researchers to invest in the bold, novel ideas of others.

Fitz Tavernier Jr., M.D., MPH, has been inducted into the Alpha Omega Alpha Honor Society - University of Michigan Chapter. He was one of nearly 40 inductees — including 34 medical students, two faculty members, and three house officers — at a ceremony that took place Friday, February 10.

Three researchers — Drs. George Mashour, Chad Brummett, and David Williams — ranked in top 7 for PI funding.

More than half of adults surveyed reported that the use of cannabis led them to decrease their pain medications.

Researchers identify new ways to characterize states of consciousness

A review of maternal deaths suggests most individuals had documented behavioral health conditions but only one-third received appropriate pharmacologic treatment before death

Nicknamed the “invisible disease”, the autoimmune disorder comes with lifestyle changes that can be a challenging adjustment.